Cheng-Hsun Chuang

Title: Innovations by Cheng-Hsun Chuang

Introduction

Cheng-Hsun Chuang is a notable inventor based in Tainan, Taiwan. He has made significant contributions to the field of medical research, particularly in cancer prognosis. With a total of 2 patents, his work focuses on innovative methods for predicting cancer outcomes.

Latest Patents

Chuang's latest patents include a method for treating and predicting the prognosis of gastric cancer patients by calculating RNA expression with logistic regression. This method involves measuring the expression levels of five specific RNAs in gastric cancer patients and comparing them to control levels. A poor prognosis is identified when the expression levels of these RNAs are lower in the patient sample than in the control. Another significant patent is related to prognosis biomarkers for triple-negative breast cancer. This patent provides a microRNA expression signature that predicts the recurrence of triple-negative breast cancer, consisting of several key miRNAs.

Career Highlights

Chuang is affiliated with National Yang Ming Chiao Tung University, where he continues to advance his research in cancer prognosis. His work has garnered attention for its potential impact on patient care and treatment strategies.

Collaborations

Chuang collaborates with esteemed colleagues, including Kuang-Wen Liao and Hsiao-Chin Hong, contributing to a dynamic research environment that fosters innovation.

Conclusion

Cheng-Hsun Chuang's contributions to cancer research through his patents highlight the importance of innovative approaches in medical science. His work not only enhances our understanding of cancer prognosis but also paves the way for improved patient outcomes.